PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2021

Aug 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2021-08-02

Reporting Person: AUERBACH ALAN H (Director, PRESIDENT AND CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-02	COMMON STOCK	S	1764	$7.5316	Disposed	4419554	Direct

Footnotes

F1: The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.